查詢結果分析
相關文獻
- Anti-angiogenic Therapies for Age-related Macular Degeneration
- 循血綠血管攝影在老年性黃斑部病變之應用及展望
- Transpupillary Thermotherapy of Choroidal Neovascularization in Patients with Age-Related Macular Degeneration
- Aflibercept治療濕性年齡相關性黃斑部退化病變
- 抗血管內皮生長因子(Anti-vascular Endothelial Growth Factor, Anti-VEGF)於視網膜疾病之應用
- 運動對血管新生幹細胞調動的影響
- 血管內皮生長因子在生醫科技與產業應用的發展
- Expression of Vascular Endothelial Growth Factor in Taiwanese Benign and Malignant Prostate Tissues
- 抗血管內皮生長因子在眼科的應用
- Angiogenesis--The Ultimate Target of Cancer Treatment
頁籤選單縮合
題名 | Anti-angiogenic Therapies for Age-related Macular Degeneration=老年性黃斑部退化的抗新生血管治療法 |
---|---|
作者 | 彭百慧; Peng, Pai-huei; |
期刊 | 輔仁醫學期刊 |
出版日期 | 20150300 |
卷期 | 13:1 2015.03[民104.03] |
頁次 | 頁1-14 |
分類號 | 416.746 |
語文 | eng |
關鍵詞 | 老年性黃斑部退化; 血管新生; 脈絡膜新生血管; 血管內皮生長因子; Age-related macular degeneration; Angiogenesis; Choroidal neovascularization; Vascular endothelial growth factor; |
中文摘要 | 老年性黃斑部退化是造成65歲以上失明的主要原因。血管內皮生長因子已被認為在形成新生血管過程中扮演重要角色,包括見於濕性老年性黃斑部退化的脈絡膜新生血管。拮抗血管內皮生長因子的活性是目前濕性老年性黃斑部退化的黃金標準治療法。除了研發更有效率及更長療效的抗血管內皮生長因子藥物,其他相關具有潛力的療法也在研究中。此篇綜論探及目前使用及近來受矚目治療老年性黃斑部退化的抗血管內皮生長因子藥物。 |
英文摘要 | Age-related macular degeneration (AMD) is the major cause of visual loss for people over the age of 65. Vascular endothelial growth factor (VEGF) has been recognized to have a critical role in angiogenesis cascade, including choroidal neovascuarization in wet AMD. Neutralization of VEGF activity is currently the gold standard treatment of wet AMD. In addition to developing new anti-VEGF agents with better efficiency and longer durability, researches on other related potential approaches are undergoing. This article reviews the available as well as the promising therapeutic agents engineered to inhibit the angiogenic pathway for the treatment of wet AMD. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。